Abstract:Objective s A transgenic ANKA strain of Plasmodium berghei was constructed to express luciferase and this strain was used to infect Kunming mice.An in vivo imaging experiment was conducted when mice exhibited clinical signs of cerebral malaria.This imaging system could further the understanding of the underlying mechanisms of cerebral malaria and it could serve as a useful tool for research on malaria vaccines or drug evaluation.Methods The recombinant plasmid p10027 was amplified and digested with a restriction enzyme.Cryopreserved protozoa were recovered and schizonts were enriched through in vitro culturing.Schizonts were transfected with the linearized plasmid.Recombinant parasites were screened for drug susceptibility and were identified with PCR.Kunming mice were infected with P.berghei ANKA-Luciferase.Six days after infection,when mice displayed typical symptoms of cerebral malaria such as hemiplegia,coma,and retinopathy,an in vivo imaging experiment was conducted to observe the proliferation and distribution of malaria parasites in mice.Afterwards,the organs of infected mice were dissected and imaged and the adhesion of parasites in various organs was evaluated.Results Both ends of the inserted fragment and the luciferase sequence were successfully amplified with PCR.The amplified fragments were 2.1 kb,2.1 kb,and 1.6 kb in length,which were consistent with expectations.Results indicated that the recombinant plasmid was successfully integrated into the genome of P.berghei ANKA.The in vivo imaging experiment indicated that infected mice had a high parasite burden when they developed cerebral malaria and parasites were distributed throughout the body.Some vital organs,such as the brain,lungs,and heart,had a high parasite burden.Imaging of organs indicated that parasites were sequestered in various important organs,and a large number of parasites had amassed in the brain in particular.Conclusion P.berghei ANKA-Luciferase was constructed and an in vivo imaging system was successfully used to study experimentally induced cerebral malaria.

A retinal model of cerebral malaria

The Ins and Outs of Cerebral Malaria Pathogenesis: Immunopathology, Extracellular Vesicles, Immunometabolism, and Trained Immunity

Pathogenic mechanisms of egress unveiled by a microvascular 3D blood-brain barrier model

Cerebral Malaria Model Applying Human Brain Organoids

Cerebral Malaria in Mouse and Man

Upregulation of Neuronal VEGF in Experimental Cerebral Malaria Coincides with Disease Severity Biomarkers in Humans: A Novel Mechanism of Pathophysiology

Cerebral Malaria and Neuronal Implications of Plasmodium Falciparum Infection: From Mechanisms to Advanced Models

Contribution of Magnetic Resonance Imaging Studies to the Understanding of Cerebral Malaria Pathogenesis

Discrete class I molecules on brain endothelium differentially regulate neuropathology in experimental cerebral malaria

Reduced cerebral blood flow and N-acetyl aspartate in a murine model of cerebral malaria

Systems-based identification of new adjunct therapies for treatment of malaria-induced cerebral pathology

Cytokines and Chemokines in Cerebral Malaria Pathogenesis

Unravelling mysteries at the perivascular space: a new rationale for cerebral malaria pathogenesis

Brain Endothelium: The “Innate Immunity Response Hypothesis” in Cerebral Malaria Pathogenesis

Re-evaluating malarial retinopathy to improve its diagnostic accuracy in cerebral malaria

Malarial retinopathy in a preschool child: A case report with long-term paediatric and ophthamological follow-up

How Does Blood-Retinal Barrier Breakdown Relate to Death and Disability in Pediatric Cerebral Malaria?

Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei

Study on the use of an in vivo imaging system to image experimentally induced cerebral malaria

Desperately Seeking Therapies for Cerebral Malaria

Endothelin-1 Mediates Brain Microvascular Dysfunction Leading to Long-Term Cognitive Impairment in a Model of Experimental Cerebral Malaria